Clinical Trial: An Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years of Age With Moderate Persistent Asthma

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07934420) titled 'An Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years of Age With Moderate Persistent Asthma' on Nov. 06.

Brief Summary: The purpose of this study is to evaluate whether budesonide and formoterol fumarate (BFF) metered-dose inhaler (MDI) is superior to BD MDI in improving lung function 1 hour post dose at Week 6 in children aged 4 to less than 12 years with moderate persistent asthma. The study will also assess safety of BFF MDI over a 6-week treatment period.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: ...